Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans
about
Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lungSystemic and mucosal immune responses in mice after mucosal immunization with group B streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate vaccine.Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.Kinetics of local and systemic immune responses after vaginal immunization with recombinant cholera toxin B subunit in humans.Protective immunity and antibody-secreting cell responses elicited by combined oral attenuated Wa human rotavirus and intranasal Wa 2/6-VLPs with mutant Escherichia coli heat-labile toxin in gnotobiotic pigs.Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunizationAntibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans.Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixedIntranasal vaccination with recombinant adeno-associated virus type 5 against human papillomavirus type 16 L1Vibrio cholerae: lessons for mucosal vaccine design.Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin aEvaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cellsOral and nasal sensitization promote distinct immune responses and lung reactivity in a mouse model of peanut allergy.Cholera toxin B-subunit gene enhances mucosal immunoglobulin A, Th1-type, and CD8+ cytotoxic responses when coadministered intradermally with a DNA vaccineIntranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.Mouse models for the study of mucosal vaccination against otitis media.Gender differences in human immunodeficiency virus type 1-specific CD8 responses in the reproductive tract and colon following nasal peptide priming and modified vaccinia virus Ankara boosting.Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly.Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.Tonsillar application of formalin-killed cells of Streptococcus sobrinus reduces experimental dental caries in rabbits.Nasal vaccination induces protective immunity without immunopathology.
P2860
Q30373884-AE99A571-0BC7-4860-A1C6-3026857514CEQ33592158-8928D58F-C742-4179-99CF-5B8293BF27F0Q33640085-BFC7C342-FF1B-4E6E-814E-975FEA79D911Q33716593-7C1C3E16-E1C1-4993-AA7B-8FBE6F913CBEQ33845547-B44E2F54-A248-43C1-AD8C-20EDDB01B97AQ33999182-A51EA831-FE3B-433B-97DA-ACB6D942F7D8Q34001107-2CE8DC50-E4E6-4804-8E8D-08F1693916C3Q34009439-DD8C2879-66A0-4DC3-9531-75E95A4C12EDQ34009698-9F338BF5-EE53-4CE5-857E-969A44B6D3A4Q34194667-9C60081E-C1E3-462F-994F-51B38FBC5F9EQ34434903-734B42C2-65C1-4443-A551-B78752DB1017Q34562952-AA71234A-3F8D-4A5C-B4A7-A1121EEBEFC1Q34581660-2B254236-18C8-4337-8156-B6BED38174C6Q34717658-7753B4C4-AC8C-4B69-BB66-DA9DF9124444Q35094515-E43DCDE7-4935-4190-885C-8B689F4F8E27Q35520692-B80F669C-2F4A-4380-AA07-28F143A7E1FDQ35550898-066E5E2D-D22D-4057-9C7E-47187E0F1285Q36978334-5F17067F-3CC0-4ECC-B0C7-4086DE08CD18Q37093093-83EFA9E8-306A-4481-B1F1-5F6AD8DB4826Q37596422-F0A6B89B-6A49-4C08-BB2D-FEEDA836E407Q37706979-14A2099A-D2FE-49CF-8E57-2D062D5A7B96Q38320741-A4A91F2B-6BCC-461B-8DFF-AA066280B400Q39509403-7D087C4D-C5C4-4D6D-96E1-FA1ED102950BQ51696284-E643D2B8-2FA0-4A8B-A232-BEEC436D06BF
P2860
Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Differential kinetics and dist ...... and oral vaccination of humans
@ast
Differential kinetics and dist ...... and oral vaccination of humans
@en
type
label
Differential kinetics and dist ...... and oral vaccination of humans
@ast
Differential kinetics and dist ...... and oral vaccination of humans
@en
prefLabel
Differential kinetics and dist ...... and oral vaccination of humans
@ast
Differential kinetics and dist ...... and oral vaccination of humans
@en
P2093
P2860
P1476
Differential kinetics and dist ...... and oral vaccination of humans
@en
P2093
C Bergquist
E L Johansson
P2860
P304
P407
P50
P577
1998-07-01T00:00:00Z